Further, the fluorescence imaging demonstrated that the SMAD2‐silenced mouse suffered more serious breast cancer bone metastasis in the femur, tibia, and vertebra, however, the SMAD3‐silenced mouse presented a contrast result. This evidence concerns the gene SMAD2 and breast carcinoma.